Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Girouard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Substance Abuse|February 14, 2019
Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populationsMichael P Girouard, Hilary Goldhammer, Alex S Keuroghlian
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
(2S*,5R*)-2,5-Dimethyl-1,4-bis-(pyridin-2-ylmeth-yl)piperazineChristopher Goh, Lilliana S Morris, Michael P Girouard, et al.
Annals of the American Thoracic Society|November 6, 2019
Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness AnalysisKrishna P Reddy, C Robert Horsburgh, Robin Wood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesMichael P Girouard, Paul E Sax, Robert A Parker, et al.
Heart Failure Reviews|October 23, 2024
Changing the paradigm in heart failure: shifting from treatment to preventionAlex J Chang, Yilin Liang, Michael P Girouard, et al.
Journal of the International AIDS Society|April 1, 2016
Survival benefits of antiretroviral therapy in Brazil: a model-based analysisPaula M Luz, Michael P Girouard, Beatriz Grinsztejn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Cost-effectiveness of genotype testing for primary resistance in BrazilPaula M Luz, Bethany L Morris, Beatriz Grinsztejn, et al.
Heart Failure Reviews|December 19, 2024
Clinical and research applications of natural language processing for heart failureMichael P Girouard, Alex J Chang, Yilin Liang, et al.
American Heart Journal|October 19, 2025
Worsening heart failure events in adults with mild-to-moderate chronic kidney diseaseLinda Ye, Michael P Girouard, Alan S Go, et al.
ESC Heart Failure|February 19, 2026
Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney diseaseSoham Patel, Kaiwen Sun, Alan S Go, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Substance Abuse|February 14, 2019
Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populationsMichael P Girouard, Hilary Goldhammer, Alex S Keuroghlian
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
(2S*,5R*)-2,5-Dimethyl-1,4-bis-(pyridin-2-ylmeth-yl)piperazineChristopher Goh, Lilliana S Morris, Michael P Girouard, et al.
Annals of the American Thoracic Society|November 6, 2019
Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness AnalysisKrishna P Reddy, C Robert Horsburgh, Robin Wood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesMichael P Girouard, Paul E Sax, Robert A Parker, et al.
Heart Failure Reviews|October 23, 2024
Changing the paradigm in heart failure: shifting from treatment to preventionAlex J Chang, Yilin Liang, Michael P Girouard, et al.
Journal of the International AIDS Society|April 1, 2016
Survival benefits of antiretroviral therapy in Brazil: a model-based analysisPaula M Luz, Michael P Girouard, Beatriz Grinsztejn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Cost-effectiveness of genotype testing for primary resistance in BrazilPaula M Luz, Bethany L Morris, Beatriz Grinsztejn, et al.
Heart Failure Reviews|December 19, 2024
Clinical and research applications of natural language processing for heart failureMichael P Girouard, Alex J Chang, Yilin Liang, et al.
American Heart Journal|October 19, 2025
Worsening heart failure events in adults with mild-to-moderate chronic kidney diseaseLinda Ye, Michael P Girouard, Alan S Go, et al.
ESC Heart Failure|February 19, 2026
Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney diseaseSoham Patel, Kaiwen Sun, Alan S Go, et al.
Pageof 1